AAAAAA
Results:
1-24
|
Results: 24
Authors:
AKAMATSU Y
MURPHY JC
NOLAN KF
THOMAS P
KREITMAN RJ
LEUNG SO
JUNGHANS RP
Citation: Y. Akamatsu et al., A SINGLE-CHAIN IMMUNOTOXIN AGAINST CARCINOEMBRYONIC ANTIGEN THAT SUPPRESSES GROWTH OF COLORECTAL-CARCINOMA CELLS, Clinical cancer research, 4(11), 1998, pp. 2825-2832
Authors:
KINGSBURY GA
WALDMANN TA
JUNGHANS RP
Citation: Ga. Kingsbury et al., EXAMINATION OF A ROLE FOR IDIOTYPY IN THE DISEASE REMISSION OF A LONG-TERM SURVIVOR ADULT T-CELL LEUKEMIA TREATED WITH ANTI-TAC ANTIBODY, Leukemia, 12(6), 1998, pp. 982-991
Authors:
JUNGHANS RP
Citation: Rp. Junghans, BONE-MARROW INVOLVEMENT IN ACUTE-LEUKEMIA, The New England journal of medicine, 339(19), 1998, pp. 1375-1375
Authors:
JUNGHANS RP
CARRASQUILLO JA
WALDMANN TA
Citation: Rp. Junghans et al., IMPACT OF ANTIGENEMIA ON THE BIOACTIVITY OF INFUSED ANTI-TAC ANTIBODY- IMPLICATIONS FOR DOSE SELECTION IN ANTIBODY IMMUNOTHERAPIES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(4), 1998, pp. 1752-1757
Authors:
HAGG DS
JUNGHANS RP
Citation: Ds. Hagg et Rp. Junghans, MEASUREMENT AND BIOLOGICAL CORRELATES OF ANTIBODY BIOACTIVITY DURING ANTIBODY IMMUNOTHERAPIES, Journal of immunological methods, 219(1-2), 1998, pp. 7-21
Authors:
JUNGHANS RP
Citation: Rp. Junghans, FINALLY, THE BRAMBELL RECEPTOR (FCRB) - MEDIATOR OF TRANSMISSION OF IMMUNITY AND PROTECTION FROM CATABOLISM FOR IGG (VOL 16, PG 29, 1997), Immunologic research, 16(2), 1997, pp. 215-215
Authors:
JUNGHANS RP
Citation: Rp. Junghans, FINALLY - THE BRAMBELL RECEPTOR (FCRB) - MEDIATOR OF TRANSMISSION OF IMMUNITY AND PROTECTION FROM CATABOLISM FOR IGG, Immunologic research, 16(1), 1997, pp. 29-57
Authors:
JUNGHANS RP
Citation: Rp. Junghans, NEXT-GENERATION FC CHIMERIC PROTEINS - AVOIDING IMMUNE-SYSTEM INTERACTIONS, Trends in biotechnology, 15(5), 1997, pp. 155-155
Authors:
JUNGHANS RP
Citation: Rp. Junghans, IGG BIOSYNTHESIS - NO IMMUNOREGULATORY FEEDBACK, Blood, 90(10), 1997, pp. 3815-3818
Authors:
JUNGHANS RP
Citation: Rp. Junghans, OPTIMIZATION OF RADIOLIGAND BINDING AND RADIOIMMUNO ASSAYS (VOL 240, PG 75, 1996), Analytical biochemistry, 251(1), 1997, pp. 133-133
Authors:
JUNGHANS RP
ZHENG G
ANDERSON CL
WATTERS JM
Citation: Rp. Junghans et al., THE BRAMBELL PROTECTION RECEPTOR (FCRP) FOR IGG CATABOLISM IS THE NEONATAL INTESTINAL TRANSPORT RECEPTOR (FCRN), The FASEB journal, 10(6), 1996, pp. 1737-1737
Authors:
JUNGHANS RP
ANDERSON CL
Citation: Rp. Junghans et Cl. Anderson, THE PROTECTION RECEPTOR FOR IGG CATABOLISM IS THE BETA(2)-MICROGLOBULIN-CONTAINING NEONATAL INTESTINAL TRANSPORT RECEPTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 93(11), 1996, pp. 5512-5516
Authors:
JUNGHANS RP
WALDMANN TA
Citation: Rp. Junghans et Ta. Waldmann, METABOLISM OF TAC (IL2R-ALPHA) - PHYSIOLOGY OF CELL-SURFACE SHEDDING AND RENAL CATABOLISM, AND SUPPRESSION OF CATABOLISM BY ANTIBODY-BINDING, The Journal of experimental medicine, 183(4), 1996, pp. 1587-1602
Authors:
JUNGHANS RP
STONE AL
LEWIS MS
Citation: Rp. Junghans et al., BIOPHYSICAL CHARACTERIZATION OF A RECOMBINANT SOLUBLE INTERLEUKIN-2 RECEPTOR (TAC) - EVIDENCE FOR A MONOMERIC STRUCTURE, The Journal of biological chemistry, 271(18), 1996, pp. 10453-10460
Authors:
JUNGHANS RP
Citation: Rp. Junghans, OPTIMIZATION OF RADIOLIGAND BINDING AND RADIOIMMUNO ASSAYS, Analytical biochemistry, 240(1), 1996, pp. 75-89
Authors:
JUNGHANS RP
KINGSBURY GA
Citation: Rp. Junghans et Ga. Kingsbury, MEDULLARY CARCINOMA OF BREAST - PLEURAL EFFUSIONS, TUMOR-TISSUE NEEDED, Journal of clinical oncology, 13(3), 1995, pp. 799-799
Authors:
KINGSBURY GA
JUNGHANS RP
Citation: Ga. Kingsbury et Rp. Junghans, SCREENING OF PHAGE DISPLAY IMMUNOGLOBULIN LIBRARIES BY ANTI-M13 ELISAAND WHOLE PHAGE PCR, Nucleic acids research, 23(13), 1995, pp. 2563-2564
Authors:
WALDMANN TA
WHITE JD
CARRASQUILLO JA
REYNOLDS JC
PAIK CH
GANSOW OA
BRECHBIEL MW
JAFFE ES
FLEISHER TA
GOLDMAN CK
TOP LE
BAMFORD R
ZAKNOEN S
ROESSLER E
KASTENSPORTES C
ENGLAND R
LITOU H
JOHNSON JA
JACKSONWHITE T
MANNS A
HANCHARD B
JUNGHANS RP
NELSON DL
Citation: Ta. Waldmann et al., RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC, Blood, 86(11), 1995, pp. 4063-4075
Authors:
CHAMOW SM
ZHANG DZ
MHATRE SM
TAN XY
MARSTERS SA
PEERS DH
BYRN RA
ASHKENAZI A
JUNGHANS RP
Citation: Sm. Chamow et al., A HUMANIZED, BISPECIFIC IMMUNOADHESIN-ANTIBODY THAT RETARGETS CD3-CELLS TO KILL CELLS INFECTED WITH HIV-1( EFFECTOR), Journal of cellular biochemistry, 1994, pp. 211-211
Authors:
KINGSBURY GA
RANA F
JUNGHANS RP
Citation: Ga. Kingsbury et al., THE RELATIONSHIP BETWEEN LEVELS OF SERUM AND MEMBRANE-BOUND IGD IN NORMAL INDIVIDUALS, Journal of cellular biochemistry, 1994, pp. 375-375
Authors:
CHAMOW SM
ZHANG DZ
TAN XY
MHATRE SM
MARSTERS SA
PEERS DH
BYRN RA
ASHKENAZI A
JUNGHANS RP
Citation: Sm. Chamow et al., A HUMANIZED, BISPECIFIC IMMUNOADHESIN-ANTIBODY THAT RETARGETS CD3(-1-INFECTED CELLS() EFFECTORS TO KILL HIV), The Journal of immunology, 153(9), 1994, pp. 4268-4280
Authors:
SCHMIDT DE
BROOKS TL
MHATRE S
JUNGHANS RP
KHAZAELI MB
Citation: De. Schmidt et al., AN ADVANCED SOLID SUPPORT FOR IMMUNOASSAYS AND OTHER AFFINITY APPLICATIONS, BioTechniques, 14(6), 1993, pp. 1020-1025
Authors:
JUNGHANS RP
DOBBS D
BRECHBIEL MW
MIRZADEH S
RAUBITSCHEK AA
GANSOW OA
WALDMANN TA
Citation: Rp. Junghans et al., PHARMACOKINETICS AND BIOACTIVITY OF 1,4,7,10-TETRA-AZACYLODODECANE N,N',N'',N'''-TETRAACETIC ACID (DOTA)-BISMUTH-CONJUGATED ANTI-TAC ANTIBODY FOR ALPHA-EMITTER (BI-212) THERAPY, Cancer research, 53(23), 1993, pp. 5683-5689
Authors:
WALDMANN TA
WHITE JD
GOLDMAN CK
TOP L
GRANT A
BAMFORD R
ROESSLER E
HORAK ID
ZAKNOEN S
KASTENSPORTES C
ENGLAND R
HORAK E
MISHRA B
DIPRE M
HALE P
FLEISHER TA
JUNGHANS RP
JAFFE ES
NELSON DL
Citation: Ta. Waldmann et al., THE INTERLEUKIN-2 RECEPTOR - A TARGET FOR MONOCLONAL-ANTIBODY TREATMENT OF HUMAN T-CELL LYMPHOTROPHIC VIRUS-I-INDUCED ADULT T-CELL LEUKEMIA, Blood, 82(6), 1993, pp. 1701-1712
Risultati:
1-24
|